echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Faith Medicine completes China's first registered clinical intravenous administration of AAV gene therapy for hemophilia B

    Faith Medicine completes China's first registered clinical intravenous administration of AAV gene therapy for hemophilia B

    • Last Update: 2022-01-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    <>


    The registered clinical study (CTR20212816) is a multi-center, single-arm, open, single-dose clinical study.


    Dr.


    Dr.


    About hemophilia

    Hemophilia is a bleeding disorder that slows the blood clotting process


    About BBM-H901 injection

    BBM-H901 injection is an AAV gene therapy drug with independent intellectual property rights of Faith Medicine.


    BBM-H901 injection is one of the earliest AAV gene therapy drugs to carry out clinical research in China.


    About Faith Medicine

    Faith Pharmaceutical Group was established in September 2016.


    Belief Medicine is committed to providing more effective and innovative solutions for single-gene genetic diseases, neurodegenerative diseases and some malignant diseases through adeno-associated virus (AAV) vector technology


    For more information, please visit:

    statements

    Certain information contained in this document contains forward-looking statements


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.